A special congressional committee has recommended a $15 billion investment to boost the United States' biotech advantage over ...

GSK is paying to access ABL Bio’s Grabody-B platform, which potentially enables therapies to cross the blood-brain barrier.

British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that alleged Pfizer's respiratory ...

Several pharma CEOs met with Chinese President Xi Jinping in Beijing. President Donald Trump's reciprocal tariffs have mostly ...

GSK is enlisting the aid of China’s Chongqing Zhifei Biological Products (Zhifei) to drive sales of its most important vaccine, Shingrix, in China over the next few years, and may also call upon ...

Multinational companies in China’s vaccine market face headwinds amid an anti-corruption crackdown and rising competition.

In this article, we are going to take a look at where GSK plc (NYSE:GSK ... As more and more US companies look to China for deals on the next promising chemical, whether in the obesity or cancer ...

AstraZeneca, GSK & partners will source 225GWh of renewable power in China, cutting emissions by 250,000 tonnes – equal to ...

World Wide Fund for Nature and global biopharma giant GSK have launched a five-year initiative to conserve and restore freshwater resources in water-stressed regions of Pakistan and India. The ...

The U.S. Food and Drug Administration on Tuesday approved GSK's drug for a common type of urinary tract infection (UTI) in ...

In this article, we are going to take a look at where GSK plc (NYSE:GSK ... will hire more people in the US compared to Europe or Asia and whether they will bring back more business to America.